Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep;103(9):3385-3398.
doi: 10.1007/s00277-023-05595-7. Epub 2023 Dec 27.

The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia

Affiliations
Review

The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia

Mengting Yang et al. Ann Hematol. 2024 Sep.

Abstract

The E2A-PBX1 gene fusion is a common translocation in B-cell acute lymphoblastic leukaemia. Patients harbouring the E2A-PBX1 fusion gene typically exhibit an intermediate prognosis. Furthermore, minimal residual disease has unsatisfactory prognostic value in E2A-PBX1 B-cell acute lymphoblastic leukaemia. However, the mechanism of E2A-PBX1 in the occurrence and progression of B-cell acute lymphoblastic leukaemia is not well understood. Here, we mainly review the roles of E2A and PBX1 in the differentiation and development of B lymphocytes, the mechanism of E2A-PBX1 gene fusion in B-cell acute lymphoblastic leukaemia, and the potential therapeutic approaches.

Keywords: B-ALL; B-cell differentiation; E2A; E2A-PBX1; PBX1.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Aspland SE, Bendall HH, Murre C (2001) The role of E2A-PBX1 in leukemogenesis. Oncogene 20:5708–5717 - PubMed
    1. Hunger SP (1996) Chromosomal translocations involving the E2A gene in acute lymphoblastic Leukemia: clinical features and molecular pathogenesis. Blood 87:1211–1224 - PubMed
    1. Inaba H, Teachey D, Annesley C, Batra S (2023) Jill Beck, Susan Colace. NCCN Guidelines Version 1.2024-Pediatric Acute Lymphoblastic Leukemia.
    1. Bijal Shah RJ, Mattison (2023) Ramzi Abboud, Peter Abdelmessieh, Patricia Aoun, Burke P W. NCCN Guidelines Version 2.2023-Acute Lymphoblastic Leukemia.
    1. Ferrando AA, Look AT (2000) Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic Leukemia. Semin Hematol 37:381–395 - PubMed

MeSH terms

Substances

LinkOut - more resources